Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × niraparib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 37 Prostatic Neoplasms 11 Breast Neoplasms 10 Fallopian Tube Neoplasms 9 Pancreatic Neoplasms 7 Glioblastoma 6 Neoplasm Metastasis 5 Endometrial Neoplasms 5 Neoplasms 4 Lung Neoplasms 4 Glioma 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Mesothelioma 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urothelial Cancer 1 Unilateral Breast Neoplasms 1

Interventions

Cisplatin 17 Gemcitabine 15 pembrolizumab 14 Radiotherapy 13 Paclitaxel 13 Radiotherapy, Intensity-Modulated 12 Carboplatin 10 Cyclophosphamide 9 Cetuximab 8 Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Docetaxel 6 Capecitabine 6 padeliporfin 5 Radiation 5 Irinotecan 5 Drug Therapy 5 poly ICLC 4 fludarabine 4 anlotinib 4 Standard of Care 4 Nivolumab 4 Leucovorin 4 Ipilimumab 4 Celecoxib 4 durvalumab 3 Sunitinib 3 Sorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡